Repeated treatment with gefitinib and alectinib in a patient with multiple EGFR-mutant and ALK-mutant lung adenocarcinomas: A case report

Multiple EGFR-mutant and ALK-mutant lung cancers are rare, and standard treatment has not been established because of the small number of cases. A 79-year-old man was found to harbor nodular shadows in right S1, right S5, and left S3. He was surgically diagnosed with stage IIB (pT3N0M0) EGFR G719X-m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yorozuya, Takafumi, Nagano, Yutaro, Chiba, Hirofumi, Imai, Yui, Yasuda, Kento, Sudo, Yuta, Taya, Tetsuya, Shioya, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941149/
https://www.ncbi.nlm.nih.gov/pubmed/33732615
http://dx.doi.org/10.1016/j.rmcr.2021.101378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941149/
https://www.ncbi.nlm.nih.gov/pubmed/33732615
http://dx.doi.org/10.1016/j.rmcr.2021.101378

Ejemplares similares